AOTI
AOTI is a global leader in advanced wound care, focused on preventing amputations through its patented Topical Wound Oxygen (TWO2®) therapy. This non-invasive treatment creates a sealed chamber around the limb, cycling pressurized oxygen with gentle compression to promote durable healing for severe and chronic wounds.
The therapy is backed by rigorous trials showing an 88% reduction in hospitalizations and a 71% reduction in amputations over 12 months. AOTI has treated over 40,000 patients worldwide and holds regulatory clearances from the FDA, CE Mark, MHRA, and Health Canada, operating with a unique rental model for complete care management.
Aerogen
Aerogen is Ireland’s largest indigenous medtech company and the global leader in acute care aerosol drug delivery. Its proprietary vibrating mesh technology transforms liquid medications into a fine, targeted aerosol, with the flagship Aerogen Solo system becoming the gold standard for treating critically ill respiratory patients in hospitals worldwide.
Aerogen’s technology is used in over 80 countries, treating more than 30 million patients. Backed by a €300 million scaling plan supported by Enterprise Ireland, the company is expanding its R&D and manufacturing while training over 50,000 clinicians annually to ensure effective adoption of its life-saving technology in ICUs and neonatal care units globally.
Nexerior
NOXERIOR is an Italian manufacturer specializing in on-site medical and industrial gas generation, with expertise dating back to the 1970s. Part of the NOVAIR Group since 2016, the company is renowned for its patented OXYSWING® PSA oxygen generators, known for modular design, energy efficiency, and high discharge pressure that often eliminates the need for boosters.
NOXERIOR holds ISO 13485 and ISO 9001 certifications, with its medical oxygen generators approved as Class IIB medical devices. Their compact, reliable systems serve healthcare facilities globally, ensuring a safe and uninterrupted supply of medical-grade oxygen for critical hospital needs.
